Molecular Diagnostics Market

“Global Molecular Diagnostics Market: Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast, 2022-2027” provides a deep and thorough evaluation of the molecular diagnostics market by product (Instruments, Reagents & Kits, Services & Software); by technology (PCR, INAAT, microarrays, hybridization, DNA sequencing, Next-generation sequencing (NGS) and other technologies); by application (infectious diseases, oncology, genetic tests, blood screening, microbiology, and other applications); by end user(hospital & academic laboratories, reference laboratories, and other end-users); and by geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa). Molecular diagnostics refers to a set of molecular biology practices that involves sequencing the DNA, RNA, or cell proteins of individuals to analyze biomarkers of potential diseases. It allows more accurate detection of diseases and infections in the early stages. It finds extensive application across oncology, pharmacogenomics, blood screening, genetic disease screening, and microbiology.

The global molecular diagnostics market is primarily driven by the rising prevalence of cancer and other infectious diseases. Furthermore, with the onset of the coronavirus disease (COVID-19) pandemic, the market has witnessed substantial growth as COVID-19 tests are performed using molecular diagnostics. Other factors, including the escalating demand for preventive medicines, rising number of point-of-care (PoC) testing devices, increasing funding for research and development (R&D), and technological advancements, are some of the other factors expected to impact the market growth. 

Beginning with a global overview, the report explores the dynamics that have a strong influence on the molecular diagnostics market and can also impact its future growth. Taking 2021 as the base year, the report covers the historical market scenarios from 2016-2021 and provides forecasts till 2027. This includes the study of value and volume trends and pricing history. Growth inducing factors, market restraints, and recent developments have also been analyzed in the report in order to provide deeper knowledge about the industry. On a regional basis, the report examines the molecular diagnostics market in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. For each of these regions, the report studies the molecular diagnostics market in detail for latest trends, outlook and opportunities. 

Segmentation by Products:

• Instruments
• Reagents & Kits
• Services & Software

Segmentation by Technology:

• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Hybridization [In Situ Hybridization & Fluorescent In Situ Hybridization (FISH)]
• DNA Sequencing and Next-generation Sequencing
• Microarray
• Other Technologies (Mass Spectrometry, Flow Cytometry, and Electrophoresis)

 Segmentation by Application:

• Infectious Diseases
• Oncology
• Genetic Tests
• Blood Screening
• Microbiology
• Other Applications (Cardiovascular Diseases, Neurological Diseases, and DNA Fingerprinting)

Segmentation by End User:

• Reference Laboratories
• Hospital/Academic Laboratories
• Other end users (Blood Banks, Local Public Health Laboratories, Home Health Agencies, Nursing Homes, Point-of-care Settings, and Self-testing)

Segmentation by Region:

• Asia-Pacific
• Europe
• Latin America
• North America
• Middle East & Africa

Competitive Landscape:

• Abbott Diagnostics
• Hologic
• Qiagen
• Roche Diagnostics
• Siemens Healthcare

The price margins for the products along with the various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the molecular diagnostics industry along with the parameters of porter’s five forces model. This model examines the degree of competition in the molecular diagnostics industry by analysing the threat posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. Swot analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities, and threats pertaining to the molecular diagnostics industry. Furthermore, the value chain analysis of the molecular diagnostics industry has also been covered in the report. This comprises all the activities in the value chain, such as the procurement of various raw materials, manufacturing and sales of the products, and their distribution.

Highlights of The Molecular Diagnostics Market

• Historical and current scenario
• Trends and developments
• Impact of COVID-19
• Market forecast
• Price analysis and forecast
• Porter’s five forces analysis
• SWOT analysis
• Value chain analysis

The report is a result of exhaustive primary and secondary research undertaken by analysts having years of experience in the molecular diagnostics industry. All the qualitative and quantitative aspects of the industry have been covered and the collected data has been analyzed and presented in the form of easily comprehensible charts, graphs, and tables.